← Evidence map

TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Cancer.

Miguel Martín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41385615